Inventors:
Harry Fong - Glen Ellyn IL, US
International Classification:
A61K 31/407, A61K 31/35, C07D 311/94, A61P 1/16, C07D 519/00, A61K 31/352
US Classification:
514411, 514456, 514455, 549396, 549386, 548431
Abstract:
The present invention comprises compositions and methods for the treatment of liver disease, particularly treatments for infection by HCV and/or HBV. The present invention comprises antiviral compositions comprising lamiridosin, derivatives of lamiridosin or iridoids that are effective in inhibiting one or more steps in the infection of cells by HCV or HBV. Methods for treating subjects, particularly humans, infected with HCV or HBV are provided.